Your browser version may not work well with NCBI's Web applications. More information here...

Recent Activity

Items 1 - 20 of 1035
of 52Next
2:

Dissecting Tn5 transposition using HIV-1 integrase diketoacid inhibitors.

Czyz A, Stillmock KA, Hazuda DJ, Reznikoff WS.

Biochemistry. 2007 Sep 25;46(38):10776-89. Epub 2007 Aug 29.

PMID: 17725323 [PubMed - indexed for MEDLINE]

3:

Probing HIV-1 integrase inhibitor binding sites with position-specific integrase-DNA cross-linking assays.

Johnson AA, Marchand C, Patil SS, Costi R, Di Santo R, Burke TR Jr, Pommier Y.

Mol Pharmacol. 2007 Mar;71(3):893-901. Epub 2006 Dec 15.

PMID: 17172465 [PubMed - indexed for MEDLINE]

4:

Binding mode prediction of strand transfer HIV-1 integrase inhibitors using Tn5 transposase as a plausible surrogate model for HIV-1 integrase.

Barreca ML, De Luca L, Iraci N, Chimirri A.

J Med Chem. 2006 Jun 29;49(13):3994-7.

PMID: 16789757 [PubMed - indexed for MEDLINE]

5:

Structure of the HIV-1 integrase catalytic domain complexed with an inhibitor: a platform for antiviral drug design.

Goldgur Y, Craigie R, Cohen GH, Fujiwara T, Yoshinaga T, Fujishita T, Sugimoto H, Endo T, Murai H, Davies DR.

Proc Natl Acad Sci U S A. 1999 Nov 9;96(23):13040-3.

PMID: 10557269 [PubMed - indexed for MEDLINE]

6:

Tn5 transposase as a useful platform to simulate HIV-1 integrase inhibitor binding mode.

Barreca ML, Ortuso F, Iraci N, De Luca L, Alcaro S, Chimirri A.

Biochem Biophys Res Commun. 2007 Nov 23;363(3):554-60. Epub 2007 Sep 14.

PMID: 17889829 [PubMed - indexed for MEDLINE]

7:

Effect of DNA modifications on DNA processing by HIV-1 integrase and inhibitor binding: role of DNA backbone flexibility and an open catalytic site.

Johnson AA, Sayer JM, Yagi H, Patil SS, Debart F, Maier MA, Corey DR, Vasseur JJ, Burke TR Jr, Marquez VE, Jerina DM, Pommier Y.

J Biol Chem. 2006 Oct 27;281(43):32428-38. Epub 2006 Aug 30.

PMID: 16943199 [PubMed - indexed for MEDLINE]

8:

Human immunodeficiency virus integrase inhibitors efficiently suppress feline immunodeficiency virus replication in vitro and provide a rationale to redesign antiretroviral treatment for feline AIDS.

Savarino A, Pistello M, D'Ostilio D, Zabogli E, Taglia F, Mancini F, Ferro S, Matteucci D, De Luca L, Barreca ML, Ciervo A, Chimirri A, Ciccozzi M, Bendinelli M.

Retrovirology. 2007 Oct 30;4:79.

PMID: 17971219 [PubMed - indexed for MEDLINE]

9:

Novel HIV integrase inhibitors with anti-HIV activity: insights into integrase inhibition from docking studies.

Cox AG, Nair V.

Antivir Chem Chemother. 2006;17(6):343-53.

PMID: 17249248 [PubMed - indexed for MEDLINE]

10:

Structural determinants for HIV-1 integrase inhibition by beta-diketo acids.

Marchand C, Zhang X, Pais GC, Cowansage K, Neamati N, Burke TR Jr, Pommier Y.

J Biol Chem. 2002 Apr 12;277(15):12596-603. Epub 2002 Jan 22.

PMID: 11805103 [PubMed - indexed for MEDLINE]

11:

Structure-activity relationships of HIV-1 integrase inhibitors--enzyme-ligand interactions.

Maurin C, Bailly F, Cotelle P.

Curr Med Chem. 2003 Sep;10(18):1795-810. Review.

PMID: 12871105 [PubMed - indexed for MEDLINE]

12:

Prediction of HIV-1 integrase/viral DNA interactions in the catalytic domain by fast molecular docking.

Adesokan AA, Roberts VA, Lee KW, Lins RD, Briggs JM.

J Med Chem. 2004 Feb 12;47(4):821-8.

PMID: 14761184 [PubMed - indexed for MEDLINE]

13:

HIV-1 integrase inhibitors that compete with the target DNA substrate define a unique strand transfer conformation for integrase.

Espeseth AS, Felock P, Wolfe A, Witmer M, Grobler J, Anthony N, Egbertson M, Melamed JY, Young S, Hamill T, Cole JL, Hazuda DJ.

Proc Natl Acad Sci U S A. 2000 Oct 10;97(21):11244-9.

PMID: 11016953 [PubMed - indexed for MEDLINE]

14:

Dihydroxythiophenes are novel potent inhibitors of human immunodeficiency virus integrase with a diketo acid-like pharmacophore.

Kehlenbeck S, Betz U, Birkmann A, Fast B, Göller AH, Henninger K, Lowinger T, Marrero D, Paessens A, Paulsen D, Pevzner V, Schohe-Loop R, Tsujishita H, Welker R, Kreuter J, Rübsamen-Waigmann H, Dittmer F.

J Virol. 2006 Jul;80(14):6883-94.

PMID: 16809294 [PubMed - indexed for MEDLINE]

15:

Identification of a small-molecule binding site at the dimer interface of the HIV integrase catalytic domain.

Molteni V, Greenwald J, Rhodes D, Hwang Y, Kwiatkowski W, Bushman FD, Siegel JS, Choe S.

Acta Crystallogr D Biol Crystallogr. 2001 Apr;57(Pt 4):536-44.

PMID: 11264582 [PubMed - indexed for MEDLINE]

16:

Modeling, analysis, and validation of a novel HIV integrase structure provide insights into the binding modes of potent integrase inhibitors.

Chen X, Tsiang M, Yu F, Hung M, Jones GS, Zeynalzadegan A, Qi X, Jin H, Kim CU, Swaminathan S, Chen JM.

J Mol Biol. 2008 Jul 11;380(3):504-19. Epub 2008 May 1.

PMID: 18565342 [PubMed - indexed for MEDLINE]

17:

Structure and function of HIV-1 integrase.

Chiu TK, Davies DR.

Curr Top Med Chem. 2004;4(9):965-77. Review.

PMID: 15134551 [PubMed - indexed for MEDLINE]

18:

Hyrtiosal, from the marine sponge Hyrtios erectus, inhibits HIV-1 integrase binding to viral DNA by a new inhibitor binding site.

Du L, Shen L, Yu Z, Chen J, Guo Y, Tang Y, Shen X, Jiang H.

ChemMedChem. 2008 Jan;3(1):173-80.

PMID: 17943714 [PubMed - indexed for MEDLINE]

19:

Changes to the HIV long terminal repeat and to HIV integrase differentially impact HIV integrase assembly, activity, and the binding of strand transfer inhibitors.

Dicker IB, Samanta HK, Li Z, Hong Y, Tian Y, Banville J, Remillard RR, Walker MA, Langley DR, Krystal M.

J Biol Chem. 2007 Oct 26;282(43):31186-96. Epub 2007 Aug 21.

PMID: 17715137 [PubMed - indexed for MEDLINE]

20:

Dicaffeoylquinic acid inhibitors of human immunodeficiency virus integrase: inhibition of the core catalytic domain of human immunodeficiency virus integrase.

Robinson WE Jr, Cordeiro M, Abdel-Malek S, Jia Q, Chow SA, Reinecke MG, Mitchell WM.

Mol Pharmacol. 1996 Oct;50(4):846-55.

PMID: 8863829 [PubMed - indexed for MEDLINE]

Items 1 - 20 of 1035
of 52Next